The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...

Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

GLP-1 medications like Ozempic have shown promise as treatment for symptoms caused by Polycystic Ovary Syndrome (PCOS). I ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...